Denver Lecture and Reception with Rick Doblin and Marcela Otalora

Lecture and Reception: Making MDMA-Assisted Therapy and Marijuana into Medicines for Posttraumatic Stress Disorder: Legal and Medical Implications

Rick Doblin, PhD
MAPS Founder & Executive Director

Marcela Ot’alora, MA, LPC
Principal Investigator, Boulder Study Site

Saturday Feb. 9, 2013
7:00 pm – 9:30
Lecture and Dessert Reception

Ricketson Law Building
Sturm College of Law, Room 180 University of Denver
Denver, Colorado

About the Research

In MAPSʼ pilot study, 83% of the subjects receiving MDMA-assisted psychotherapy no longer met the criteria for PTSD; these benefits were sustained an average of 3.8 years later. MAPSʼ FDA- approved study treating PTSD with marijuana is now blocked by NIDA and the DEA. MAPS is suing DEA in the 1st Circuit Court of Appeals in an effort to end the government monopoly on the supply of marijuana for use in federally regulated research.

About MAPS

The Multidisciplinary Association for Psychedelic Studies (MAPS) is a not-for-profit research and educational organization that develops medical, legal and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. Founded in 1986, MAPS highest priority is to develop MDMA-assisted psychotherapy into a prescription drug for posttraumatic stress disorder (PTSD). Studies are underway in Charleston, SC and Beer Yaakov, Israel. Studies are about to begin in Boulder, Colorado, and Vancouver, Canada. Studies have been completed in the US and Switzerland.

University of Denver, Denver, CO